| Product Code: ETC8539120 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the Netherlands continued to rely on import shipments of gammaretroviral vectors, with top exporting countries being Belgium, Hungary, USA, Japan, and Sweden. The market remained highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). Despite a moderate compound annual growth rate (CAGR) of 3.85% from 2020 to 2024, there was a significant decline in the growth rate from 2023 to 2024, with a decrease of -42.93%. This fluctuation may indicate shifting market dynamics or regulatory changes impacting the import of gammaretroviral vectors into the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Gammaretroviral Vector Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Gammaretroviral Vector Market Revenues & Volume, 2022 & 2032F |
3.3 Netherlands Gammaretroviral Vector Market - Industry Life Cycle |
3.4 Netherlands Gammaretroviral Vector Market - Porter's Five Forces |
3.5 Netherlands Gammaretroviral Vector Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Netherlands Gammaretroviral Vector Market Revenues & Volume Share, By Disease Type, 2022 & 2032F |
3.7 Netherlands Gammaretroviral Vector Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Netherlands Gammaretroviral Vector Market Revenues & Volume Share, By End-User, 2022 & 2032F |
4 Netherlands Gammaretroviral Vector Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in the Netherlands |
4.2.2 Growing investments in research and development for gene therapy |
4.2.3 Favorable government regulations and policies supporting gene therapy market growth |
4.3 Market Restraints |
4.3.1 High cost associated with gammaretroviral vector therapy |
4.3.2 Concerns regarding the safety and efficacy of gene therapy treatments |
5 Netherlands Gammaretroviral Vector Market Trends |
6 Netherlands Gammaretroviral Vector Market, By Types |
6.1 Netherlands Gammaretroviral Vector Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Lentiviral Vectors, 2022 - 2032F |
6.1.4 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Adenoviral Vectors, 2022 - 2032F |
6.1.5 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Adeno-Associated Viral Vectors, 2022 - 2032F |
6.1.6 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Netherlands Gammaretroviral Vector Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Cancer, 2022 - 2032F |
6.2.3 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Genetic Disorders, 2022 - 2032F |
6.2.4 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Infectious Diseases, 2022 - 2032F |
6.2.5 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Netherlands Gammaretroviral Vector Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Gene Therapy, 2022 - 2032F |
6.3.3 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Vaccinology, 2022 - 2032F |
6.4 Netherlands Gammaretroviral Vector Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical, 2022 - 2032F |
6.4.3 Netherlands Gammaretroviral Vector Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
7 Netherlands Gammaretroviral Vector Market Import-Export Trade Statistics |
7.1 Netherlands Gammaretroviral Vector Market Export to Major Countries |
7.2 Netherlands Gammaretroviral Vector Market Imports from Major Countries |
8 Netherlands Gammaretroviral Vector Market Key Performance Indicators |
8.1 Number of clinical trials using gammaretroviral vectors in the Netherlands |
8.2 Funding levels for gene therapy research and development projects |
8.3 Adoption rates of gammaretroviral vector therapies in clinical settings |
9 Netherlands Gammaretroviral Vector Market - Opportunity Assessment |
9.1 Netherlands Gammaretroviral Vector Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Netherlands Gammaretroviral Vector Market Opportunity Assessment, By Disease Type, 2022 & 2032F |
9.3 Netherlands Gammaretroviral Vector Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Netherlands Gammaretroviral Vector Market Opportunity Assessment, By End-User, 2022 & 2032F |
10 Netherlands Gammaretroviral Vector Market - Competitive Landscape |
10.1 Netherlands Gammaretroviral Vector Market Revenue Share, By Companies, 2025 |
10.2 Netherlands Gammaretroviral Vector Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here